SFO
JNJ icon

Stokes Family Office’s Johnson & Johnson JNJ Stock Holding History

Stokes Family Office’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Sell
48,385
-7,912
-14% -$1.84M 1.43% 12
2026
Q1 		$13.8M Sell
56,297
-4,380
-7% -$1.02M 1.42% 13
2025
Q4 		$12.6M Buy
60,677
+600
+1% +$119K 1.15% 20
2025
Q3 		$11.1M Buy
60,077
+1,725
+3% +$296K 1.06% 25
2025
Q2 		$8.91M Buy
58,352
+750
+1% +$115K 0.94% 32
2025
Q1 		$9.55M Sell
57,602
-1,137
-2% -$178K 1.07% 24
2024
Q4 		$8.49M Sell
58,739
-896
-2% -$139K 0.91% 24
2024
Q3 		$9.66M Sell
59,635
-9,336
-14% -$1.49M 1.06% 22
2024
Q2 		$10.1M Sell
68,971
-2,326
-3% -$346K 1.18% 20
2024
Q1 		$11.3M Buy
71,297
+243
+0.3% +$38.7K 1.41% 17
2023
Q4 		$11.1M Sell
71,054
-18,463
-21% -$2.83M 1.5% 14
2023
Q3 		$13.9M Buy
89,517
+874
+1% +$144K 1.64% 11
2023
Q2 		$14.7M Buy
88,643
+2,145
+2% +$346K 1.7% 11
2023
Q1 		$13.4M Sell
86,498
-4,010
-4% -$648K 1.67% 12
2022
Q4 		$16M Buy
90,508
+695
+0.8% +$120K 2.06% 10
2022
Q3 		$14.7M Sell
89,813
-1,450
-2% -$245K 2.09% 9
2022
Q2 		$16.2M Sell
91,263
-1,334
-1% -$238K 2.21% 9
2022
Q1 		$16.4M Buy
92,597
+938
+1% +$160K 2.18% 9
2021
Q4 		$15.7M Sell
91,659
-906
-1% -$148K 1.95% 10
2021
Q3 		$14.9M Buy
92,565
+2,262
+3% +$386K 2.07% 10
2021
Q2 		$14.9M Buy
90,303
+377
+0.4% +$62.4K 2.11% 9
2021
Q1 		$14.8M Buy
89,926
+2,430
+3% +$393K 2.3% 8
2020
Q4 		$13.8M Buy
87,496
+330
+0.4% +$48.7K 2.71% 6
2020
Q3 		$13M Buy
87,166
+3,226
+4% +$477K 2.94% 5
2020
Q2 		$11.8M Buy
83,940
+444
+0.5% +$64.7K 2.98% 5
2020
Q1 		$10.9M Buy
83,496
+2,155
+3% +$306K 2.92% 7
2019
Q4 		$11.9M Buy
+81,341
New +$11M 2.64% 7

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stokes Family Office's JNJ Position: Q2 2026 in Review

Stokes Family Office reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $1.84M and leaving 48,385 shares worth $12.3M. The position accounts for 1.43% of the portfolio, ranked #12.

Stokes Family Office first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $16.4M in Q1 2022. 4,688 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stokes Family Office held 48,385 shares of Johnson & Johnson worth $12.3M as of Q2 2026.
  • Stokes Family Office sold 7,912 Johnson & Johnson shares in Q2 2026, an estimated $1.84M.
  • Johnson & Johnson made up 1.43% of Stokes Family Office's portfolio in Q2 2026, its #12 holding.
  • Stokes Family Office first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Stokes Family Office's Johnson & Johnson position peaked at $16.4M in Q1 2022.
  • 4,688 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.